Stryker expands Mako robotics portfolio with full market release of Mako RPS

Rhea-AI Summary

Stryker (NYSE: SYK) announced the U.S. commercial launch of Mako RPS (Robotic Power System) for total knee replacement on July 16, 2026. The system debuts the Mako Handheld Robotics platform, extending the Mako portfolio beyond robotic-arm assisted surgery into a new orthopaedic robotics category.

Mako RPS combines intraoperative planning with a robotically enabled saw and Stryker’s patented active adjustment technology, designed to respond to surgeons’ hand movements and help maintain alignment with the surgical plan. It is compatible with Stryker’s Triathlon Total Knee System and built to work with the Q Guidance System, expanding Stryker’s enabling technologies ecosystem.

Positive

• U.S. commercial launch of Mako RPS handheld robotic system for total knee
• Portfolio expansion into a new handheld orthopaedic robotics category
• Integration with Triathlon Total Knee System and Q Guidance ecosystem

Negative

• None.

News Market Reaction – SYK

+4.66%

8 alerts

+4.66% Session close to close

$119.25B Market Cap

0.1x Rel. Volume

In the Jul 16 session, SYK gained 4.66%, reflecting a moderate positive market reaction. Our momentum scanner triggered 8 alerts that day, indicating moderate trading interest and price volatility.

Data tracked by StockTitan Argus on the day of publication.

Market Context

Set against low reported short positioning and recent net insider selling of 156,425 shares, this Ma...

Analysis

Set against low reported short positioning and recent net insider selling of 156,425 shares, this Mako RPS launch adds to Stryker’s robotics story without an obvious structural risk flag. Investors may watch how adoption trends compare with prior product launches and broader medtech peers’ growth signals.

Key Figures

Orthopaedic procedures: more than 2.5 million procedures Countries with Mako: 47 countries

2 metrics

Orthopaedic procedures more than 2.5 million procedures Mako procedures performed worldwide

Countries with Mako 47 countries Geographic reach of Mako orthopaedic robotics

Historical Context

5 past events · Latest: Jul 01 (Neutral)

Pattern 5 events

Date	Event	Sentiment	24h Move	Catalyst
Jul 01	earnings date notice	Neutral	-0.5%	Scheduled webcast and release timing for Q2 2026 financial results.
Jun 24	marketing partnership	Positive	+1.2%	Partnership with golfer Shane Lowry to promote joint replacement awareness.
Jun 02	product launch	Positive	-2.1%	Launch of TPX HD power tool for demanding orthopaedic procedures.
May 26	product launch	Positive	-1.1%	European launch of Pangea Plating System with first clinical case completed.
May 19	acquisition agreement	Positive	+1.3%	Agreement to acquire Amplitude Vascular Systems for up to $835M.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Recent product and deal announcements have produced mixed single-day reactions, with both gains and pullbacks following ostensibly positive news.

Key Terms

intraoperative planning, robotic-arm assisted, orthopaedic robotics

3 terms

intraoperative planning medical

"Mako RPS combines robotic execution, intraoperative planning and a familiar handheld"

Planning that happens during a surgical procedure, using real-time imaging, measurements, software, or navigation tools to guide immediate decisions about where and how to operate. It matters to investors because technologies and devices that enable precise intraoperative planning can affect procedure success, shorten operation time, change hospital costs and reimbursement, and influence regulatory approval and market adoption of surgical products—similar to updating a map while you’re already driving.

robotic-arm assisted technical

"expanding the Mako portfolio beyond robotic-arm assisted surgery."

A description for medical procedures in which a robotic arm—an electronically controlled mechanical arm guided by a surgeon or computer system—helps perform or assist surgical tasks such as cutting, suturing, or positioning instruments. Think of it like a precise power tool or camera-stabilizer that extends a surgeon’s hands. It matters to investors because use of robotic-arm assistance can change equipment sales, training and maintenance costs, regulatory approval paths, hospital purchasing decisions, and potential clinical outcomes that influence revenue and market adoption.

orthopaedic robotics medical

"further expanding the Mako portfolio into a new category of orthopaedic robotics."

Robotic systems, instruments, and software designed to assist surgeons with bone and joint procedures by using sensors, imaging, planning tools, and mechanical arms to improve precision in tasks like cutting, implant placement, and alignment. It matters to investors because adoption can shift procedure costs, hospital purchasing, recurring sales of instruments and software, and competitive positions in medical device markets—think of it as adding a GPS and power tools to traditional manual surgery.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

New handheld robotic technology expands the Mako platform and brings Mako robotic-assisted knee replacement to a new segment of the orthopaedic market

• Stryker announced the U.S. commercial launch of Mako RPS (Robotic Power System) for total knee replacement procedures.
• The launch introduces Mako Handheld Robotics, expanding the Mako portfolio beyond robotic-arm assisted surgery.
• Mako RPS combines robotic execution, intraoperative planning and a familiar handheld power tool workflow.

PORTAGE, Mich., July 16, 2026 /PRNewswire/ -- Stryker (NYSE: SYK), a global leader in medical technologies, announced today the U.S. commercial launch of Mako RPS^® (Robotic Power System) for total knee replacement procedures, further expanding the Mako portfolio into a new category of orthopaedic robotics.

The launch marks the introduction of the Mako Handheld Robotics platform, alongside the Mako SmartRobotics™ with Mako 4, Stryker's multi-specialty robotic-arm assisted platform. Designed to provide surgeons with an intuitive handheld robotic experience, Mako RPS combines Stryker's expertise in robotics and power tools to bring robotic technology to a new customer segment of the orthopaedic market.

"Customer response during the limited market release has been exceptionally strong," said Keith Evans, VP/GM of Stryker's Mako and Enabling Technologies business. "As we expand the Mako portfolio, we're proud to set a new standard for what customers can expect from a handheld robotics technology – bringing together robotics, power tool expertise and a deep understanding of surgical workflows."

As healthcare providers increasingly seek flexibility in how robotic technology is incorporated into orthopaedic procedures, Mako RPS offers a new option that blends robotic execution with a familiar surgical experience. The launch expands access to Mako, offering surgeons more robotic options and bringing Mako to a broader range of customers and care settings.

Compatible with Stryker's clinically proven^1-2 Triathlon^® Total Knee System, Mako RPS for Total Knee features intraoperative planning and a robotically enabled saw equipped with Stryker's patented active adjustment technology, which responds to a surgeon's hand movements and helps maintain alignment with the surgical plan in real time. The system provides a familiar cutting experience without the need for cutting blocks, offering an option for surgeons interested in adopting robotic technology while integrating easily into their existing surgical workflows.

"By combining robotic technology with the clinically proven Triathlon® Total Knee System, Mako RPS delivers an intuitive surgical experience that builds on the implant and workflow familiarity surgeons know and trust^2-3," said Lisa Kloes, vice president and general manager of Stryker's Knee business.

Built to work with Stryker's multi-specialty Q Guidance System, Mako RPS expands Stryker's ecosystem of enabling technologies across the continuum of orthopaedic care and sites of service.

For more than two decades, Mako has defined orthopaedic robotics worldwide. With more than 2.5 million procedures performed in 47 countries, Mako continues to advance the adoption of robotics in orthopaedics and support surgeons in delivering personalized patient care.

About Stryker
Stryker is a global leader in medical technologies and, together with our customers, we are driven to make healthcare better. We offer innovative products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Alongside our customers around the world, we impact more than 150 million patients annually. More information is available at www.stryker.com.

Media contact
Stryker
Jenny Braga
Senior Director, External Affairs
jenny.braga@stryker.com

References:

1. American Joint Replacement Registry (AJRR): 2025 Annual Report. Rosemont, IL: American Academy of Orthopaedic Surgeons (AAOS), 2025.
2. Australian Orthopaedic Association National Joint Replacement Registry (AOANJRR). Hip, Knee & Shoulder Arthroplasty Annual Report 2025. AOA;2025. https://aoanjrr.sahmri.com/. Accessed 11 Oct. 2025
3. Scott CEH, Snowden GT, Cawley W, et al. Fifteen-year prospective longitudinal cohort study of outcomes following single radius total knee arthroplasty. Bone Jt Open. 2023;4(10):808-816. Published 2023 Oct 24.doi:10.1302/2633-1462.410.BJO-2023-0086.R1

View original content to download multimedia:https://www.prnewswire.com/news-releases/stryker-expands-mako-robotics-portfolio-with-full-market-release-of-mako-rps-302826896.html

SOURCE Stryker

FAQ

What did Stryker (SYK) announce about Mako RPS on July 16, 2026?

Stryker announced the U.S. commercial launch of its Mako RPS handheld robotic system for total knee replacements. According to Stryker, this expands the Mako portfolio into a new handheld robotics category within orthopaedics, complementing its existing Mako SmartRobotics robotic-arm platform.

What is Mako RPS in Stryker's Mako robotics portfolio for SYK investors?

Mako RPS is a handheld Robotic Power System for total knee replacement procedures. According to Stryker, it combines intraoperative planning with a robotically enabled saw and active adjustment technology, aiming to provide surgeons with an intuitive, familiar power-tool-based surgical workflow.

How does Mako RPS differ from Stryker's existing Mako SmartRobotics platform?

Mako RPS introduces a handheld robotics platform, while Mako SmartRobotics uses a robotic arm. According to Stryker, Mako RPS blends robotic execution with a traditional power tool workflow, offering surgeons an additional option for robotic-assisted total knee replacement procedures.

Which knee implant system is compatible with Stryker's Mako RPS for total knee replacement?

Mako RPS for Total Knee is compatible with Stryker’s Triathlon Total Knee System. According to Stryker, the system offers intraoperative planning and an actively adjusting robotic saw, designed to build on the implant and workflow familiarity that surgeons already know from Triathlon.

How does Mako RPS integrate with Stryker's Q Guidance System and enabling technologies?

Mako RPS is built to work with Stryker’s multi-specialty Q Guidance System. According to Stryker, this integration expands its ecosystem of enabling technologies across orthopaedic care, supporting different sites of service and offering more flexible robotic solutions in knee replacement.

How many procedures have been performed with Stryker's Mako technology worldwide?

Stryker reports that more than 2.5 million Mako procedures have been performed in 47 countries. According to Stryker, this two-decade history underscores Mako’s established role in orthopaedic robotics and its contribution to the global adoption of robotic-assisted orthopaedic surgery.